NEW YORK (GenomeWeb) – Precision Therapeutics, formerly Skyline Medical, announced today that it has signed a letter of intent to acquire the shares of Helomics that it does not currently own. The firm acquired a 25 percent equity stake in Helomics in December.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.